Amantadine-HCL treatment of chronic hepatitis C in non-responders to alpha-interferon.

被引：0
|
作者：
Parolin, MB [1 ]
Lacerda, MA [1 ]
Lopes, RW [1 ]
机构：
[1] Univ Fed Parana, Div Gastroenterol Hepatol, BR-80060000 Curitiba, Parana, Brazil
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2208
引用
收藏
页码：714A / 714A
页数：1
相关论文
共 50 条
  • [41] Cyclic and periodic interferon treatment with n.interferon β plus HLBI is effective for non-responders with chronic hepatitis C.
    Kishida, Y
    Naitoh, M
    Katayama, K
    Kashiwagi, T
    Hayashi, N
    Kinoshita, M
    HEPATOLOGY, 1999, 30 (04) : 617A - 617A
  • [42] Non-responders to sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection
    Karimi-Sari, Hamidreza
    Rezaee-Zavareh, Mohammad Saeid
    Falade-Nwulia, Oluwaseun
    Lim, Joseph K.
    JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 1215 - 1217
  • [43] The Role of Autophagy in Interferon/Ribavirin Responders and Non-Responders with Hepatitis C Virus Infection
    Abbasi, Fahimeh
    Bamdad, Taravat
    Ghadimi-Moghadam, Abdolkarim
    Chubin, Hamzeh
    Jamalidoust, Marzieh
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2020, 13 (03)
  • [44] Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course
    Salmerón, J
    Vivaldi, RM
    De la Mata, M
    Romero, M
    Moreno, JP
    Aguilar, J
    Palacios, A
    Nogueras, F
    Vignote, M
    Alcántara, R
    Suarez, E
    Andrade, R
    Rodriguez, L
    Sanchez, H
    Quintero, D
    JOURNAL OF HEPATOLOGY, 2000, 32 : 185 - 185
  • [45] Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders
    Kao, JH
    Lai, MY
    Chen, PJ
    Cheng, YM
    Chen, DS
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2001, 100 (10) : 662 - 667
  • [46] Retreatment of chronic hepatitis C in previous non-responders and relapsers
    Satoskar, Rohit
    Jensen, Donald M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (15) : 2491 - 2503
  • [47] Cytokines in patients with chronic hepatitis C:: Comparison between responders and non-responders to interferon alfa2b.
    Fernández, JL
    Silva, M
    Eiras, G
    Rendo, P
    Pérez, V
    Vidal, A
    Criscuolo, M
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 462 - 462
  • [48] Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy
    VanThiel, DH
    Friedlander, L
    Molloy, PJ
    Kania, RJ
    Fagiuoli, S
    Wright, HI
    Gasbarrini, A
    Caraceni, P
    HEPATO-GASTROENTEROLOGY, 1996, 43 (12) : 1557 - 1561
  • [49] A combined therapy with high dose of interferon (IFN)-alpha as an induction and ribavirin in non-responders to IFN alone with chronic hepatitis C
    Takashimizu, S
    Watanabe, N
    Mine, T
    Matsuzaki, S
    GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
  • [50] Retreatment with interferon-α at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients
    Okanoue, T
    Daimon, Y
    Kirishima, T
    Ohnishi, N
    Nakamura, H
    Nagao, Y
    Minami, M
    Itoh, Y
    HEPATOLOGY RESEARCH, 2001, 20 (03) : 348 - 358
12345